FDA.reportPublic FDA data

Phenazopyridine Hydrochloride

Product NDC
51293-810
11-digit product format
512930810
Labeler code
51293
Product ID
51293-810_1c1118af-aafb-40a7-9967-13751b416918
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Phenazopyridine
Dosage form
TABLET
Route
ORAL
Labeler
ECI Pharmaceuticals, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2011-02-01
Marketing end
0000-00-00
Substance
PHENAZOPYRIDINE HYDROCHLORIDE
Active strength
100 mg/1
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51293-810-012026-01-22C16284748780-1d6a99b39-9b39-a426-e053-dadaa90af4c2c2049b62-04d7-44a4-968c-a1e7fccb0125
51293-810-012022-01-28C16284748780-1d6a99b39-9b39-a426-e053-dadaa90af4c2c2049b62-04d7-44a4-968c-a1e7fccb0125

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51293-810-01EA - Each51293-810a40e0a1a-0dd7-4431-952b-fb7cad7c81af12015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PHENAZOPYRIDINE HYDROCHLORIDEACTIVE INGREDIENT0EWG668W17PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
PHENAZOPYRIDINEACTIVE MOIETYK2J09EMJ52PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZPHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOPHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1APHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
POVIDONESINACTIVE INGREDIENTFZ989GH94EPHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJPHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51293-810PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [ECI PHARMACEUTICALS, LLC]6Legacy NDC20201228_c2049b62-04d7-44a4-968c-a1e7fccb0125.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1094107phenazopyridine HCl 100 MG Oral TabletPSNb4d22d69-b225-46b8-84a1-52321bb888041
1094104phenazopyridine HCl 200 MG Oral TabletPSNb4d22d69-b225-46b8-84a1-52321bb888041
1094107phenazopyridine hydrochloride 100 MG Oral TabletSCDb4d22d69-b225-46b8-84a1-52321bb888041
1094104phenazopyridine hydrochloride 200 MG Oral TabletSCDb4d22d69-b225-46b8-84a1-52321bb888041

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51293-810-0151293081001100 TABLET in 1 BOTTLE (51293-810-01) 100 tablet2011-02-010000-00-00NoNoCurrent